InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Mcglynn Margaret G, Director. Insider active across 4 companies, notably Amicus Therapeutics, INC.. Aggregated, 22 reports have been published. Split: 0 buy · 1 sell. Total volume traded: €180k. Activity tracked since 1 May 2021. The latest transaction was filed on 27 April 2026 (Disposition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Mcglynn Margaret G
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
94,631 shares@ US$14.500.029% mcap75.7% of flowCommon StockSEC:0001193125-26-182284:0
10,420 shares0Common StockSEC:0001593968-25-000784:0
20,414 shares0Common StockSEC:0000950170-25-083225:0
2,029 shares@ US$4.90100.0% of flowCommon StockSEC:0001104659-25-009785:0
6,670 shares0Common StockSEC:0001593968-24-000865:0
11,847 shares0Common StockSEC:0000950170-24-071002:0
7,500 shares@ US$2.805.2% of flowCommon StockSEC:0000950170-24-027334:0
3,100 sharesCommon StockSEC:0001209191-23-036754:0
8,584 shares0Common StockSEC:0001209191-23-036434:0
15,000 shares@ US$3.3212.2% of flowCommon StockSEC:0001209191-23-003573:0
15,000 shares@ US$13.025847.9% of flowCommon StockSEC:0001209191-23-003573:1
700 sharesCommon StockSEC:0001209191-22-038594:0
12,671 shares0Common StockSEC:0001209191-22-035836:0
15,000 shares@ US$4.790.0015% mcap52.3% of flowCommon StockSEC:0001209191-22-027245:0
921 sharesCommon StockSEC:0000899243-22-016336:0
5,000 shares@ US$127.540.0005% mcap25.4% of flowCommon StockSEC:0000899243-22-014548:0
5,000 shares@ US$127.540.0005% mcap25.0% of flowCommon StockSEC:0000899243-22-013305:0
5,000 shares@ US$127.540.0005% mcap24.8% of flowCommon StockSEC:0001209191-22-005895:0
10,115 shares0Common StockSEC:0001209191-21-040392:0
699 sharesCommon StockSEC:0001209191-21-037619:0
10,000 shares@ US$7.514.0% of flowCommon StockSEC:0001209191-21-030441:0
921 shares0Common StockSEC:0001209191-21-029861:0
22 of 22 declarations
About Mcglynn Margaret G
MCGLYNN MARGARET G is Director at Amicus Therapeutics, INC., Vertex Pharmaceuticals INC / MA and NOVAVAX INC. They have filed 22 disclosures in total. In the sampled recent filings, sales amount to EUR 1350340, over the period from 2021-05-04 to 2026-04-27, and the most frequent transaction nature is Exercise of options.
